191 related articles for article (PubMed ID: 12383888)
1. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes.
Jakub JW; Diaz NM; Ebert MD; Cantor A; Reintgen DS; Dupont EL; Shons AR; Cox CE
Am J Surg; 2002 Oct; 184(4):302-6. PubMed ID: 12383888
[TBL] [Abstract][Full Text] [Related]
2. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
Pargaonkar AS; Beissner RS; Snyder S; Speights VO
Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer.
Gray RJ; Pockaj BA; Conley CR
Ann Surg Oncol; 2004 Dec; 11(12):1056-60. PubMed ID: 15545503
[TBL] [Abstract][Full Text] [Related]
8. Lymph node metastasis in patients with frozen section analyses that are negative for tumors.
Lee SK; Lee KW; Kim S; Choi MY; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Lee JE; Yang JH; Nam SJ
Oncology; 2012; 83(1):31-7. PubMed ID: 22722529
[TBL] [Abstract][Full Text] [Related]
9. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node.
Schreiber RH; Pendas S; Ku NN; Reintgen DS; Shons AR; Berman C; Boulware D; Cox CE
Ann Surg Oncol; 1999; 6(1):95-101. PubMed ID: 10030421
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer.
Choi YJ; Yun HR; Yoo KE; Kim JH; Nam SJ; Choi YL; Ko YH; Kim BT; Yang JH
Jpn J Clin Oncol; 2006 Aug; 36(8):489-93. PubMed ID: 16790449
[TBL] [Abstract][Full Text] [Related]
11. Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.
Bassi KK; Seenu V; Ballehaninna UK; Parshad R; Chumber S; Dhar A; Gupta SD; Kumar R; Srivastava A
Indian J Cancer; 2006; 43(3):103-9. PubMed ID: 17065767
[TBL] [Abstract][Full Text] [Related]
12. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.
Cohen LF; Breslin TM; Kuerer HM; Ross MI; Hunt KK; Sahin AA
Am J Surg Pathol; 2000 Sep; 24(9):1266-72. PubMed ID: 10976701
[TBL] [Abstract][Full Text] [Related]
13. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
Mullenix PS; Brown TA; Meyers MO; Giles LR; Sigurdson ER; Boraas MC; Hoffman JP; Eisenberg BL; Torosian MH
Am J Surg; 2005 May; 189(5):606-9; discussion 609. PubMed ID: 15862505
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.
Turner RR; Ollila DW; Krasne DL; Giuliano AE
Ann Surg; 1997 Sep; 226(3):271-6; discussion 276-8. PubMed ID: 9339933
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
[TBL] [Abstract][Full Text] [Related]
16. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
17. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer.
Wong SL; Chao C; Edwards MJ; Simpson D; McMasters KM;
Am J Surg; 2001 Oct; 182(4):330-4. PubMed ID: 11720665
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
[TBL] [Abstract][Full Text] [Related]
19. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
20. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
Aslani N; Swanson T; Kennecke H; Woods R; Davis N
Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
